PharmAthene (PIP) Crumbles: Stock Falls by 7.1% - Tale of the Tape

Loading...
Loading...
PharmAthene, Inc. (PIP) saw a big move last session, as the company's shares fell by over 7% on the day. The move came on pretty good volume too with far more shares changing hands than in a normal session. This continues the recent downtrend for PIP, as the stock is now down over 29% in the past one-month time frame.

This biodefense company has seen a flat track record when it comes to current year estimate revisions over the past few weeks, and the consensus for earnings hasn't been in a trend either. This recent price action is discouraging, so make sure to keep a close watch on this firm in the near future, and especially on earnings estimates following the recent slump.

PharmAthene currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.0%.

Some better-ranked stocks in the same sector include Astellas Pharma, Inc. (ALPMY), Grifols, S.A. (GRFS) and Cardiome Pharma Corp. (CRME). Astellas Pharma and Cardiome Pharma carry a Zacks Rank #2 (Buy) while Grifols carries Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


ASTELLAS PHARMA (ALPMY): Get Free Report

CARDIOME PHARMA (CRME): Get Free Report

GRIFOLS SA-ADR (GRFS): Free Stock Analysis Report

PHARMATHENE INC (PIP): Get Free Report

To read this article on Zacks.com click here.
Loading...
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...